Midazolam sublingual film - Aoxing Pharmaceutical Company

Drug Profile

Midazolam sublingual film - Aoxing Pharmaceutical Company

Alternative Names: Midazolam oral film

Latest Information Update: 21 Jun 2011

Price : $50

At a glance

  • Originator Aoxing Pharmaceutical Company
  • Class Benzodiazepines; Hypnosedatives; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Phase Unknown Anxiety disorders; Insomnia; Sleep disorders

Most Recent Events

  • 17 Jun 2011 Investigation in Anxiety disorders in China (Sublingual)
  • 17 Jun 2011 Investigation in Insomnia in China (Sublingual)
  • 17 Jun 2011 Investigation in Sleep disorders in China (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top